Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers

Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers

US Patent 9334330 · Granted May 10, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic 2023
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strat2020
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strat2018
Neurotensin analogues for radioisotope targeting to neurotensin receptor-positiv2017
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Formulation for the oromucosal, in particular pernasal, route2001
Rotor blade with swivelling air flow control flap2000
Gyroplane rotor braking unit1995